Nashville Lung Cancer Screening Trial

If you have a high risk of lung cancer and are between the ages of 55-80 or have a significant smoking history, we encourage you to participate in a lung cancer screening trial. The purpose of the screening trial is to test established and possible early detection screening tools. Individuals who enroll will be offered a series of screening tests, which includes a lung function test and CT scan (X-ray imaging) of the chest. Patients will also be asked for blood or urine samples. study timeline

Basic Study Inclusion Criteria

55-80 years of age
Current smoker or
Former smoker

Locations

Vanderbilt University Medical Center (VUMC)
Tennessee Valley Health Care Systems Veterans Affairs-Nashville (TVHSVA)
Community centers for underserved populations

Dr. Pierre Massion, the clinical trial's principal investigator, and team will help determine those who are at greatest risk for developing lung cancer and enroll them into the screening program. The team hopes to develop a proven test to determine who is at greater risk for lung cancer as well as allow providers to screen the people who need it the most.

Detecting Lung Cancer Early

This is a clinical study funded by the Early Detection Research Network (NCI) as part of the activity of the Clinical Validation Center awarded to Dr. P. Massion in October 2010.

Read an interview from Dr. Massion about the Nashville Lung Cancer Screening Trial.

Contact the Research Team

Name	Phone	Role
Hina Chowdhry	(615) 936-0753	Research Coordinator
Sophie Chiron Jouan	(615) 343-0688	Research Coordinator
Pierre P. Massion, M.D.	(615) 835-7842	Principal Investigator
VICC Clinical Trials Information	1 (800) 811-8480

Referring Providers
Please discuss lung cancer screening with your patients. If your patient would like to hear more about the study, please send a message basket to Hina Chowdhry or Sophie Chiron Jouan in StarPanel.

Other Resources

Smoking Cessation

Tennessee Tobacco Quit Line

National Resources